Arie Belldegrun

ALLO

Arie Belldegrun serves as Director at Allogene Therapeutics, Inc. (ALLO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$6.95M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$6.95M

Companies Traded

ALLO

Active Period

Jan 2022 – May 2024

2 total trades

Most Recent

Buy ALLO

May 16, 2024 · $5.00M

Arie Belldegrun's Insider Trading at Allogene Therapeutics, Inc. (ALLO)

Buys

2 · $6.95M

Sells

0 · $0.00

Total Shares Bought

1,879,176

Total Shares Sold

ALLO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 16, 2024↗	Buy	1,724,137	$2.90	$5.00M	0
Jan 12, 2022↗	Buy	155,039	$12.60	$1.95M	0

Related Insiders

Benjamin Machinas Beneski

officer: SVP, Chief Technical Officer

ALLOSell · Mar 2, 2026

Benjamin Machinas Beneski

SVP, Chief Technical Officer

ALLOSell · Feb 2, 2026

David D Chang

director, officer: President and CEO

ALLOSell · Feb 2, 2026

David D Chang

President and CEO

ALLOSell · Feb 2, 2026

Earl Martin Douglas

officer: SVP, General Counsel

ALLOSell · Feb 2, 2026

Earl Martin Douglas

SVP, General Counsel

ALLOSell · Feb 2, 2026

Geoffrey M. Parker

CHIEF FINANCIAL OFFICER

ALLOSell · Feb 2, 2026

Geoffrey M. Parker

officer: CHIEF FINANCIAL OFFICER

ALLOSell · Feb 2, 2026

Explore More Insider Trading Data

ALLO Insider Trading Activity

View all insider trades at Allogene Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity